Literature DB >> 33463684

COVID-19 Pandemic Planning: Simulation Models to Predict Biochemistry Test Capacity for Patient Surges.

Martha E Lyon1, Andrew Bajkov2, Diane Haugrud1, Barry D Kyle1, Fang Wu1, Andrew W Lyon1.   

Abstract

BACKGROUND: Patient surges beyond hospital capacity during the initial phase of the COVID-19 pandemic emphasized a need for clinical laboratories to prepare test processes to support future patient care. The objective of this study was to determine if current instrumentation in local hospital laboratories can accommodate the anticipated workload from COVID-19 infected patients in hospitals and a proposed field hospital in addition to testing for non-infected patients.
METHODS: Simulation models predicted instrument throughput and turn-around-time for chemistry, ion-selective-electrode, and immunoassay tests using vendor-developed software with different workload scenarios. The expanded workload included tests from anticipated COVID patients in 2 local hospitals and a proposed field hospital with a COVID-specific test menu in addition to the pre-pandemic workload.
RESULTS: Instrumentation throughput and turn-around time at each site was predicted. With additional COVID-patient beds in each hospital, the maximum throughput was approached with no impact on turnaround time. Addition of the field hospital workload led to significantly increased test turnaround times at each site.
CONCLUSIONS: Simulation models depicted the analytic capacity and turn-around times for laboratory tests at each site and identified the laboratory best suited for field hospital laboratory support during the pandemic. © American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  COVID19; pandemic; simulation model; surge capacity planning

Year:  2020        PMID: 33463684     DOI: 10.1093/jalm/jfaa231

Source DB:  PubMed          Journal:  J Appl Lab Med        ISSN: 2475-7241


  1 in total

1.  The response of total testing process in clinical laboratory medicine to COVID-19
pandemic.

Authors:  Funda Eren; Merve Ergin Tuncay; Esra Firat Oguz; Salim Neselioglu; Ozcan Erel
Journal:  Biochem Med (Zagreb)       Date:  2021-06-15       Impact factor: 2.313

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.